The SARS response--building and assessing an evidence-based approach to future global microbial threats

Editorial

James M Hughes. JAMA. 2003.

. 2003 Dec 24;290(24):3251-3.

doi: 10.1001/jama.290.24.3251.

No abstract available

Comment on

Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003.
Pang X, Zhu Z, Xu F, Guo J, Gong X, Liu D, Liu Z, Chin DP, Feikin DR. Pang X, et al. JAMA. 2003 Dec 24;290(24):3215-21. doi: 10.1001/jama.290.24.3215. JAMA. 2003. PMID: 14693874
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study.
Loutfy MR, Blatt LM, Siminovitch KA, Ward S, Wolff B, Lho H, Pham DH, Deif H, LaMere EA, Chang M, Kain KC, Farcas GA, Ferguson P, Latchford M, Levy G, Dennis JW, Lai EK, Fish EN. Loutfy MR, et al. JAMA. 2003 Dec 24;290(24):3222-8. doi: 10.1001/jama.290.24.3222. JAMA. 2003. PMID: 14693875
Ethical and legal challenges posed by severe acute respiratory syndrome: implications for the control of severe infectious disease threats.
Gostin LO, Bayer R, Fairchild AL. Gostin LO, et al. JAMA. 2003 Dec 24;290(24):3229-37. doi: 10.1001/jama.290.24.3229. JAMA. 2003. PMID: 14693876